Epidarex Capital IV is a Bethesda-based venture capital fund managed by Epidarex Capital. €125m reported at first close (source published January 2026).
Turn academic breakthrough science into early-stage healthcare companies by leading financings and building leadership teams (up to 15 companies).
Amounts come from the linked public source. A first close is not the final fund size, and a reported close does not confirm that the fund is investing now. Headquarters describe where the manager is based, not where it invests.